ARTS-HF
A randomized, double-blind, double-dummy, multi-center study to assess safety and efficacy of BAY 94-8862 in chronic heart failure with left ventricular systolic dysfunction and type 2 diabetes mellitus and / or chronic kidneydisease versus eplerenone.
- Stadium
- klaar
- Middel
- BAY 94-8862
- Populatie
- Hartfalen
- Fase
- IIb
- First Patient In
- 15 maart 2013
- Last Patient In
- 15 december 2013
- Last Patient Last Visit
- -
Studiedirecteur
